TreeWAS – Variant ID: rs488333

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.000	0.899	0.101
K86.1 Other chronic pancreatitis	0.030	0.970	0.000
E61.1 Iron deficiency	0.025	0.975	0.000
T43.2 Other and unspecified antidepressants	0.023	0.977	0.000
R21 Rash and other nonspecific skin eruption	0.000	0.978	0.022
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.019	0.981	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.016	0.984	0.000
T43.6 Psychostimulants with abuse potential	0.016	0.984	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.015	0.984	0.000
T43.9 Psychotropic drug, unspecified	0.015	0.985	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.014	0.985	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.014	0.986	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.012	0.988	0.000
T40.2 Other opioids	0.010	0.990	0.000
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.000	0.990	0.010
E61 Deficiency of other nutrient elements	0.010	0.990	0.000
N32.9 Bladder disorder, unspecified	0.010	0.990	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.991	0.009
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.991	0.009
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.991	0.009
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.009	0.991	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.009	0.991	0.000
K70.0 Alcoholic fatty liver	0.009	0.991	0.000
K70 Alcoholic liver disease	0.008	0.992	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.992	0.008
K70.1 Alcoholic hepatitis	0.008	0.992	0.000
K70.3 Alcoholic cirrhosis of liver	0.008	0.992	0.000
R22.0 Localised swelling, mass and lump, head	0.000	0.992	0.008
R23 Other skin changes	0.000	0.992	0.008
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.008	0.992	0.000
K86 Other diseases of pancreas	0.007	0.993	0.000
E61.9 Deficiency of nutrient element, unspecified	0.007	0.993	0.000
E61.8 Deficiency of other specified nutrient elements	0.007	0.993	0.000
E61.7 Deficiency of multiple nutrient elements	0.007	0.993	0.000
E61.6 Vanadium deficiency	0.007	0.993	0.000
E61.5 Molybdenum deficiency	0.007	0.993	0.000
E61.4 Chromium deficiency	0.007	0.993	0.000
E61.3 Manganese deficiency	0.007	0.993	0.000
E61.0 Copper deficiency	0.007	0.993	0.000
K70.4 Alcoholic hepatic failure	0.007	0.993	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.007	0.993	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.007	0.993	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.993	0.007
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.007	0.993	0.000
K60.2 Anal fissure, unspecified	0.007	0.993	0.000
K86.3 Pseudocyst of pancreas	0.007	0.993	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.007	0.993	0.000
N04.9 Unspecified	0.007	0.993	0.000
T40.3 Methadone	0.007	0.993	0.000
R23.2 Flushing	0.000	0.993	0.007
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.006	0.993	0.000
T40.8 Lysergide [LSD]	0.006	0.993	0.000
T40.7 Cannabis (derivatives)	0.006	0.993	0.000
T40.0 Opium	0.006	0.993	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T40.4 Other synthetic narcotics	0.006	0.994	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.006	0.994	0.000
E61.2 Magnesium deficiency	0.006	0.994	0.000
T40.1 Heroin	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
R23.0 Cyanosis	0.000	0.994	0.006
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
R23.1 Pallor	0.000	0.994	0.006
T38.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
T40.5 Cocaine	0.006	0.994	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.994	0.006
T47.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.994	0.006
R23.4 Changes in skin texture	0.000	0.994	0.006
T47.0 Histamine H(2)-receptor antagonists	0.006	0.994	0.000
T38.9 Other and unspecified hormone antagonists	0.006	0.994	0.000
T38.7 Androgens and anabolic congeners	0.006	0.994	0.000
T38.5 Other oestrogens and progestogens	0.006	0.994	0.000
T38.4 Oral contraceptives	0.006	0.994	0.000
T38.2 Antithyroid drugs	0.006	0.994	0.000
T38.1 Thyroid hormones and substitutes	0.006	0.994	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.994	0.000
T48.5 Anti-common-cold drugs	0.005	0.994	0.000
R23.3 Spontaneous ecchymoses	0.000	0.994	0.006
K60.0 Acute anal fissure	0.006	0.994	0.000
T40.6 Other and unspecified narcotics	0.005	0.994	0.000
I69 Sequelae of cerebrovascular disease	0.000	0.995	0.005
T38.0 Glucocorticoids and synthetic analogues	0.005	0.995	0.000
K60.3 Anal fistula	0.005	0.995	0.000
K61.0 Anal abscess	0.005	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.005	0.995	0.000
T48.4 Expectorants	0.005	0.995	0.000
T48.3 Antitussives	0.005	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.005	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.995	0.000
T48.0 Oxytocic drugs	0.005	0.995	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.995	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.000	0.995	0.005
I47.1 Supraventricular tachycardia	0.005	0.995	0.000
K60 Fissure and fistula of anal and rectal regions	0.005	0.995	0.000
M20.4 Other hammer toe(s) (acquired)	0.000	0.995	0.005
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.995	0.000
T37.5 Antiviral drugs	0.005	0.995	0.000
T37.4 Anthelminthics	0.005	0.995	0.000
T37.3 Other antiprotozoal drugs	0.005	0.995	0.000
T37.1 Antimycobacterial drugs	0.005	0.995	0.000
T37.0 Sulphonamides	0.005	0.995	0.000
T42.3 Barbiturates	0.005	0.995	0.000
T42.4 Benzodiazepines	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
T47.2 Stimulant laxatives	0.005	0.995	0.000
H40.2 Primary angle-closure glaucoma	0.005	0.995	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.000	0.995	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
K86.8 Other specified diseases of pancreas	0.005	0.995	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.005	0.995	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.005	0.995	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.005	0.995	0.000
T41.5 Therapeutic gases	0.005	0.995	0.000
T41.4 Anaesthetic, unspecified	0.005	0.995	0.000
T41.3 Local anaesthetics	0.005	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.005	0.995	0.000
T41.1 Intravenous anaesthetics	0.005	0.995	0.000
T41.0 Inhaled anaesthetics	0.005	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.995	0.005
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
R22.2 Localised swelling, mass and lump, trunk	0.000	0.995	0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
T47.4 Other laxatives	0.004	0.995	0.000
I69.3 Sequelae of cerebral infarction	0.000	0.995	0.005
T47.6 Antidiarrhoeal drugs	0.004	0.995	0.000
T49.9 Topical agent, unspecified	0.004	0.995	0.000
T49.8 Other topical agents	0.004	0.995	0.000
T49.7 Dental drugs, topically applied	0.004	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.995	0.000
T49.2 Local astringents and local detergents	0.004	0.995	0.000
T49.1 Antipruritics	0.004	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.004	0.995	0.000
T50.5 Appetite depressants	0.004	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.004	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.004	0.995	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.004	0.995	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.005	0.995	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
K70.9 Alcoholic liver disease, unspecified	0.004	0.996	0.000
K86.9 Disease of pancreas, unspecified	0.004	0.996	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.004	0.996	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
S82.60 Fracture of lateral malleolus (closed)	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
R50.8 Other specified fever	0.000	0.996	0.004
S72.1 Pertrochanteric fracture	0.000	0.996	0.004
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.996	0.004
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
F05.9 Delirium, unspecified	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
T44.0 Anticholinesterase agents	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
I46.0 Cardiac arrest with successful resuscitation	0.004	0.996	0.000
R50.0 Fever with chills	0.000	0.996	0.004
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.996	0.004
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.996	0.004
T45.4 Iron and its compounds	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.000	0.996	0.004
Z90.6 Acquired absence of other parts of urinary tract	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.996	0.000
K60.1 Chronic anal fissure	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
T36.6 Rifamycins	0.003	0.996	0.000
T36.5 Aminoglycosides	0.003	0.996	0.000
T36.2 Chloramphenicol group	0.003	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
C73 Malignant neoplasm of thyroid gland	0.003	0.997	0.000
N04 Nephrotic syndrome	0.003	0.997	0.000
K60.4 Rectal fistula	0.003	0.997	0.000
R50 Fever of unknown origin	0.000	0.997	0.003
K60.5 Anorectal fistula	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
D46 Myelodysplastic syndromes	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
S72.11 Pertrochanteric fracture (open)	0.000	0.997	0.003
D09.0 Bladder	0.003	0.997	0.000
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.000	0.997	0.003
R50.1 Persistent fever	0.000	0.997	0.003
T36.4 Tetracyclines	0.003	0.997	0.000
N04.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
D46.2 Refractory anaemia with excess of blasts	0.000	0.997	0.003
R50.2 Drug-induced fever	0.000	0.997	0.003
G72.0 Drug-induced myopathy	0.000	0.997	0.003
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.000	0.997	0.003
R20 Disturbances of skin sensation	0.000	0.997	0.003
D46.1 Refractory anaemia with sideroblasts	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
D03 Melanoma in situ	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
G72.9 Myopathy, unspecified	0.000	0.997	0.003
G72 Other myopathies	0.000	0.997	0.003
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.000	0.997	0.003
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.000	0.997	0.003
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.000	0.997	0.003
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.000	0.997	0.003
G72.8 Other specified myopathies	0.000	0.997	0.003
S22.00 Fracture of thoracic vertebra (closed)	0.003	0.997	0.000
D46.7 Other myelodysplastic syndromes	0.000	0.997	0.003
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.997	0.003
R23.8 Other and unspecified skin changes	0.000	0.997	0.003
Z97.8 Presence of other specified devices	0.000	0.997	0.003
D46.5 Refractory anaemia with multi-lineage dysplasia	0.000	0.997	0.003
G72.1 Alcoholic myopathy	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.003	0.997	0.000
R20.1 Hypoaesthesia of skin	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
C88 Malignant immunoproliferative diseases	0.000	0.997	0.003
T17.2 Foreign body in pharynx	0.003	0.997	0.000
G30.0 Alzheimer's disease with early onset	0.000	0.997	0.003
N04.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N04.6 Dense deposit disease	0.003	0.997	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.997	0.003
R20.3 Hyperaesthesia	0.000	0.997	0.003
N04.0 Minor glomerular abnormality	0.003	0.997	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.000	0.997	0.003
D46.3 Refractory anaemia with excess of blasts with transformation	0.000	0.997	0.003
D46.0 Refractory anaemia without sideroblasts, so stated	0.000	0.997	0.003
K86.2 Cyst of pancreas	0.003	0.997	0.000
M25.86 Other specified joint disorders (Lower leg)	0.003	0.997	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
D03.8 Melanoma in situ of other sites	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.997	0.000
G12.2 Motor neuron disease	0.000	0.997	0.003
N04.8 Other	0.002	0.997	0.000
D46.4 Refractory anaemia, unspecified	0.000	0.997	0.002
N04.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.997	0.002
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
D03.7 Melanoma in situ of lower limb, including hip	0.003	0.997	0.000
D03.0 Melanoma in situ of lip	0.002	0.997	0.000
S22.30 Fracture of rib (closed)	0.000	0.997	0.002
T39.0 Salicylates	0.002	0.998	0.000
D03.9 Melanoma in situ, unspecified	0.002	0.998	0.000
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.000	0.998	0.002
G72.3 Periodic paralysis	0.000	0.998	0.002
G72.2 Myopathy due to other toxic agents	0.000	0.998	0.002
D04.1 Skin of eyelid, including canthus	0.002	0.998	0.000
D04 Carcinoma in situ of skin	0.002	0.998	0.000
Z53 Persons encountering health services for specifie procedures, not carried out	0.000	0.998	0.002
D09 Carcinoma in situ of other and unspecified sites	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
D04.4 Skin of scalp and neck	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.998	0.002
C88.7 Other malignant immunoproliferative diseases	0.000	0.998	0.002
C88.3 Immunoproliferative small intestinal disease	0.000	0.998	0.002
C88.2 Gamma heavy chain disease	0.000	0.998	0.002
C88.1 Alpha heavy chain disease	0.000	0.998	0.002
F05 Delirium, not induced by alcohol and other psychoactive substances	0.000	0.998	0.002
D04.9 Skin, unspecified	0.002	0.998	0.000
I25.5 Ischaemic cardiomyopathy	0.002	0.998	0.000
F05.8 Other delirium	0.000	0.998	0.002
R20.0 Anaesthesia of skin	0.000	0.998	0.002
G72.4 Inflammatory myopathy, not elsewhere classified	0.000	0.998	0.002
C92 Myeloid leukaemia	0.000	0.998	0.002
D03.1 Melanoma in situ of eyelid, including canthus	0.002	0.998	0.000
D07.5 Prostate	0.002	0.998	0.000
J34.3 Hypertrophy of nasal turbinates	0.000	0.998	0.002
N75.1 Abscess of Bartholin's gland	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.001	0.998	0.001
D04.0 Skin of lip	0.002	0.998	0.000
M93.9 Osteochondropathy, unspecified	0.000	0.998	0.002
K61 Abscess of anal and rectal regions	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
D04.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.002	0.998	0.000
Z53.1 Procedure not carried out because of patient's decision for reasons of belief or group pressure	0.000	0.998	0.002
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.998	0.002
I98 Other disorders of circulatory system in diseases classified elsewhere	0.002	0.998	0.000
D03.4 Melanoma in situ of scalp and neck	0.002	0.998	0.000
D04.8 Skin of other sites	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
D09.3 Thyroid and other endocrine glands	0.002	0.998	0.000
D09.2 Eye	0.002	0.998	0.000
Q21.0 Ventricular septal defect	0.000	0.998	0.002
D00-D09 In situ neoplasms	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
D09.9 Carcinoma in situ, unspecified	0.002	0.998	0.000
D30.3 Bladder	0.002	0.998	0.000
F05.1 Delirium superimposed on dementia	0.000	0.998	0.002
K61.1 Rectal abscess	0.002	0.998	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.002	0.998	0.000
G30 Alzheimer's disease	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
D04.5 Skin of trunk	0.002	0.998	0.000
L30.9 Dermatitis, unspecified	0.000	0.998	0.002
C71.8 Overlapping lesion of brain	0.000	0.998	0.002
D04.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
G30.9 Alzheimer's disease, unspecified	0.000	0.998	0.002
K61.2 Anorectal abscess	0.002	0.998	0.000
S80.8 Other superficial injuries of lower leg	0.002	0.998	0.000
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
D09.7 Carcinoma in situ of other specified sites	0.002	0.998	0.000
M35.3 Polymyalgia rheumatica	0.002	0.998	0.000
C74 Malignant neoplasm of adrenal gland	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
D09.1 Other and unspecified urinary organs	0.002	0.998	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
D04.2 Skin of ear and external auricular canal	0.002	0.998	0.000
H40.8 Other glaucoma	0.002	0.998	0.000
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.002	0.998	0.000
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
I98.0 Cardiovascular syphilis	0.002	0.998	0.000
Z81.8 Family history of other mental and behavioural disorders	0.000	0.998	0.002
C74.0 Cortex of adrenal gland	0.002	0.998	0.000
D37.4 Colon	0.002	0.998	0.000
G30.1 Alzheimer's disease with late onset	0.000	0.998	0.002
H40.0 Glaucoma suspect	0.002	0.998	0.000
S82.6 Fracture of lateral malleolus	0.002	0.998	0.000
B02.9 Zoster without complication	0.002	0.998	0.000
C74.9 Adrenal gland, unspecified	0.002	0.998	0.000
F05.0 Delirium not superimposed on dementia, so described	0.000	0.998	0.002
T17 Foreign body in respiratory tract	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.000	0.998	0.002
D03.5 Melanoma in situ of trunk	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.998	0.002
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.998	0.002
O73.0 Retained placenta, without haemorrhage	0.000	0.998	0.002
R63.0 Anorexia	0.000	0.998	0.002
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.000	0.998	0.002
C91 Lymphoid leukaemia	0.000	0.998	0.002
D07 Carcinoma in situ of other and unspecified genital organs	0.002	0.998	0.000
C91.5 Adult T-cell leukaemia	0.000	0.998	0.002
D04.7 Skin of lower limb, including hip	0.002	0.998	0.000
G30.8 Other Alzheimer's disease	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.000	0.998	0.002
I46.1 Sudden cardiac death, so described	0.002	0.998	0.000
K71 Toxic liver disease	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.998	0.001
N71.1 Chronic inflammatory disease of uterus	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.000	0.998	0.002
D01 Carcinoma in situ of other and unspecified digestive organs	0.001	0.998	0.000
D00.0 Lip, oral cavity and pharynx	0.001	0.998	0.000
H61.0 Perichondritis of external ear	0.000	0.998	0.002
K61.4 Intrasphincteric abscess	0.001	0.998	0.000
T17.5 Foreign body in bronchus	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.998	0.002
I46 Cardiac arrest	0.002	0.998	0.000
C74.1 Medulla of adrenal gland	0.001	0.998	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.002	0.998	0.000
K70-K77 Diseases of liver	0.002	0.998	0.000
D00.1 Oesophagus	0.001	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.001	0.998	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.001	0.998	0.000
D00.2 Stomach	0.001	0.998	0.000
K71.0 Toxic liver disease with cholestasis	0.001	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.998	0.002
S22.0 Fracture of thoracic vertebra	0.001	0.998	0.000
M89.88 Other specified disorders of bone (Other)	0.001	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.001
K71.1 Toxic liver disease with hepatic necrosis	0.001	0.998	0.000
Z73.3 Stress, not elsewhere classified	0.000	0.998	0.002
S02.60 Fracture of mandible (closed)	0.000	0.998	0.001
C84.4 Peripheral T-cell lymphoma	0.000	0.998	0.001
D07.0 Endometrium	0.001	0.998	0.000
K71.9 Toxic liver disease, unspecified	0.001	0.998	0.000
T17.4 Foreign body in trachea	0.001	0.998	0.000
T17.1 Foreign body in nostril	0.001	0.998	0.000
T17.0 Foreign body in nasal sinus	0.001	0.998	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.001	0.999	0.000
C75.1 Pituitary gland	0.001	0.999	0.000
C82.2 Large cell, follicular	0.000	0.999	0.001
D01.5 Liver, gallbladder and bile ducts	0.001	0.999	0.000
K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma	0.000	0.999	0.001
R22.1 Localised swelling, mass and lump, neck	0.000	0.999	0.001
T17.8 Foreign body in other and multiple parts of respiratory tract	0.001	0.999	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.999	0.001
C91.7 Other lymphoid leukaemia	0.000	0.999	0.001
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.999	0.001
C91.3 Prolymphocytic leukaemia	0.000	0.999	0.001
C91.2 Subacute lymphocytic leukaemia	0.000	0.999	0.001
D07.6 Other and unspecified male genital organs	0.001	0.999	0.000
D07.3 Other and unspecified female genital organs	0.001	0.999	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.001	0.999	0.000
C94 Other leukaemias of specified cell type	0.000	0.999	0.001
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified	0.000	0.999	0.001
R50.9 Fever, unspecified	0.000	0.999	0.001
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.999	0.001
D02 Carcinoma in situ of middle ear and respiratory system	0.001	0.999	0.000
H40 Glaucoma	0.001	0.999	0.000
M23.49 Loose body in knee-Unspec lig/men	0.001	0.999	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.999	0.001
C86.4 Blastic NK-cell lymphoma	0.000	0.999	0.001
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.999	0.001
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.999	0.001
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.999	0.001
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.999	0.001
D01.3 Anus and anal canal	0.001	0.999	0.000
I27.0 Primary pulmonary hypertension	0.001	0.999	0.000
K06.1 Gingival enlargement	0.000	0.999	0.001
K71.8 Toxic liver disease with other disorders of liver	0.001	0.999	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.001	0.999	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.001	0.999	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.001	0.999	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.001	0.999	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.001	0.999	0.000
K71.2 Toxic liver disease with acute hepatitis	0.001	0.999	0.000
K73 Chronic hepatitis, not elsewhere classified	0.001	0.999	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.999	0.001
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.999	0.001
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.999	0.001
C84.3 Lymphoepithelioid lymphoma	0.000	0.999	0.001
C84.2 T-zone lymphoma	0.000	0.999	0.001
C84.1 Sezary's diease	0.000	0.999	0.001
D01.9 Digestive organ, unspecified	0.001	0.999	0.000
D01.7 Other specified digestive organs	0.001	0.999	0.000
D01.4 Other and unspecified parts of intestine	0.001	0.999	0.000
D01.1 Rectosigmoid junction	0.001	0.999	0.000
D01.0 Colon	0.001	0.999	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.000	0.999	0.001
J17.2 Pneumonia in mycoses	0.000	0.999	0.001
C93 Monocytic leukaemia	0.000	0.999	0.001
E50-E64 Other nutritional deficiencies	0.001	0.999	0.000
S82.61 Fracture of lateral malleolus (open)	0.001	0.999	0.000
C75.8 Pluriglandular involvement, unspecified	0.001	0.999	0.000
C75.5 Aortic body and other paraganglia	0.001	0.999	0.000
C75.4 Carotid body	0.001	0.999	0.000
C75.3 Pineal gland	0.001	0.999	0.000
C75.2 Craniopharyngeal duct	0.001	0.999	0.000
C75.0 Parathyroid gland	0.001	0.999	0.000
C91.9 Lymphoid leukaemia, unspecified	0.000	0.999	0.001
K76.6 Portal hypertension	0.001	0.999	0.000
D06 Carcinoma in situ of cervix uteri	0.001	0.999	0.000
C48.2 Peritoneum, unspecified	0.000	0.999	0.001
C82.3 Follicular lymphoma grade IIIa	0.000	0.999	0.001
K61.3 Ischiorectal abscess	0.001	0.999	0.000
G12 Spinal muscular atrophy and related syndromes	0.000	0.999	0.001
S22.01 Fracture of thoracic vertebra (open)	0.001	0.999	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.999	0.001
C82.5 Diffuse follicle centre lymphoma	0.000	0.999	0.001
H61.2 Impacted cerumen	0.000	0.999	0.001
T17.3 Foreign body in larynx	0.001	0.999	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.999	0.001
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.999	0.001
S22.3 Fracture of rib	0.000	0.999	0.001
S51.9 Open wound of forearm, part unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations